Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jazz710
    Member
    • Oct 2012
    • 41

    Quantitative ChIP-Seq: Normalization of Library?

    Hello all,

    I'm posting today about some basic ChIP-seq experimental design thoughts. The goal of the experiment is to quantitatively compare the genomic occupancy of a histone variant in developing vertebrate embryos across development stages and across different rearing conditions.

    To briefly explain my experiment: I have 24 IP samples (+24 input samples) which represent sampling of vertebrate embryos from two species, two treatments, and each comparing three developmental embryonic stages each with two biological replicates. (2 species*2 treatments *3 stages*2 replicates=24)

    I want to make the following quantitative measures of histone occupancy:

    1) Within species and treatment, across developmental stages
    2) Within species and developmental stage, across treatments
    3) Within developmental stage and treatment, across species

    I would like for these analysis to be quantitative which is why I have included an input sample for each IP sample.

    Currently, I am doing a 10% input method (ie. I do my IP on 1000ul of chromatin, and my input on 100ul). The goal (as I'm using the Illumina TruSeq ChIP-seq kit) is to get between 5-10ng of ChIP DNA per IP and to proceed onto analysis (currently planning to use Bowtie/MACS). As I actually do the IP reactions, I'm finding (not surprisingly) that some stages produce more IP product than others as the samples are physically different sizes. The input samples always produce plenty of DNA (>70ng per sample)

    Finally, my question:

    For truly quantitative ChIP-seq which is more important?

    1) Always prepping your IP and input in the same ratio (ie. 10% input)
    2) Adding the same amount of IP DNA and Input DNA to the library prep?

    My gut tells me that Option 2 is more important. If I do my library prep with 10ng of Input (from 1 single Input DNA extraction) and 10ng of IP (pooled from multiple IPs) that is still appropriate for quantitative analysis, right?

    Thanks for your help with this! I'm also going to chat to some folks at my University that do ChIP-seq, but I figure I'd ask here too since there's such a great knowledgebase here.

    Best,
    Bob
  • jazz710
    Member
    • Oct 2012
    • 41

    #2
    After talking with folks (including Illumina), Option 2 is appropriate. Matching your input and IP samples loaded into library prep gives you quantifiability.

    I had the 10% input idea in my head because my protocol is derived from a qPCR ChIP assay where that was integral in comparisons between samples.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:17 PM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...